GCKR rs780094: Understanding Your Metabolic Trait Variant
The rs780094 variant is a common genetic change located in the GCKR gene. It is widely studied for its associations with metabolic traits, including fasting blood glucose, serum triglyceride levels, and a modified risk for type 2 diabetes.
What each genotype means
Baseline metabolic profile
This genotype is considered the major allele in many populations. Research indicates that individuals with this genotype typically exhibit higher fasting plasma glucose levels and lower fasting triglyceride levels compared to those carrying the T allele. These associations are statistical observations across large populations and do not constitute a medical diagnosis.
This is a common genotype found globally, though exact frequencies vary significantly by ancestry.
Intermediate metabolic association
Carrying one copy of the T allele is associated with a shift toward lower fasting plasma glucose and higher fasting triglyceride levels. This variant is widely studied in the context of metabolic traits, including insulin sensitivity and type 2 diabetes risk. Please discuss any concerns regarding your metabolic health or lab results with your clinician.
This heterozygous genotype is common in many populations, including those of European and East Asian descent.
Associated with altered lipid/glucose
The T allele is consistently associated with lower fasting plasma glucose levels and higher fasting triglyceride levels in various ethnic groups. Some studies also suggest a potential link to reduced risk of type 2 diabetes and variations in insulin sensitivity. Because these traits are complex and influenced by many factors, please consult your healthcare provider to interpret these findings in the context of your overall health.
This genotype is common, though its prevalence varies by population, with significant representation in European and Asian cohorts.
What is the rs780094 Variant?
The rs780094 variant is a single nucleotide polymorphism (SNP) found within the GCKR gene, which provides instructions for making the glucokinase regulatory protein. In genetics, a SNP represents a variation at a single position in the DNA sequence. This specific variant is considered a common polymorphism, meaning it occurs frequently across diverse human populations. Researchers identify this variant by its unique reference SNP ID (rsID), which serves as a standardized label in genomic databases. Because it is located in a region of the genome that influences metabolic regulation, it has become a primary focus in genome-wide association studies (GWAS) aimed at understanding the genetic architecture of complex metabolic conditions. By comparing the DNA of individuals with different metabolic profiles, scientists have established that this specific site is a key marker for variations in how the body processes glucose and fats.
The Role of the GCKR Gene
The GCKR gene encodes the glucokinase regulatory protein (GKRP). This protein plays a critical role in the liver by regulating the activity of glucokinase, an enzyme that acts as a glucose sensor. Under certain conditions, GKRP binds to glucokinase and sequesters it in the cell nucleus, effectively inhibiting its ability to process glucose. When blood glucose levels rise, the protein releases glucokinase, allowing it to move into the cytoplasm and facilitate the conversion of glucose into glycogen for storage. Because this mechanism is central to maintaining blood sugar homeostasis, any variation in the GCKR gene—such as the rs780094 variant—can potentially alter the efficiency of this regulatory process. Research suggests that the variant may influence the activity levels of this protein, which in turn impacts how the liver manages glucose uptake and lipid metabolism, ultimately affecting circulating levels of triglycerides and insulin.
Research and Metabolic Associations
Extensive research has linked the rs780094 variant to several metabolic traits. Studies have consistently observed that the minor allele (A) is associated with elevated fasting serum triglyceride levels and reduced fasting insulin levels. Interestingly, this same allele has been associated with a modestly decreased risk of type 2 diabetes in various populations. While these statistical associations are robust, the evidence strength is considered moderate because the exact biological mechanism remains complex and potentially influenced by other genetic and environmental factors. Some studies indicate that the variant may improve insulin sensitivity, which could explain the observed reduction in diabetes risk despite the increase in triglycerides. It is important to note that these findings are based on large-scale population data and represent statistical trends rather than individual clinical outcomes. The relationship between this variant and metabolic health is nuanced, and researchers continue to investigate how it interacts with other genes and lifestyle factors.
Population Frequency
The rs780094 variant is a common polymorphism found globally. While allele frequencies can vary between different ancestral groups, the minor allele is present at a significant frequency in many populations, making it a widely studied marker in international metabolic research.
Interpreting Your Genetic Information
Understanding your genotype for rs780094 provides insight into your genetic predisposition regarding specific metabolic markers, but it does not provide a medical diagnosis. Genetic associations are statistical probabilities observed across large groups of people and cannot predict an individual's health status with certainty. Many factors, including diet, physical activity, and other genetic variants, play a much larger role in determining your actual blood glucose and triglyceride levels. If you have concerns about your metabolic health, such as high triglycerides or blood sugar levels, it is essential to consult with a healthcare professional. They can interpret your clinical lab results in the context of your overall health history. Never use genetic information to make decisions about medication or treatment plans without first discussing them with your doctor or a qualified pharmacist, as they are the only ones who can provide personalized medical advice.
How common is this variant?
The rs780094 variant is a common polymorphism with a high minor allele frequency observed across diverse global populations.
Frequently asked questions
Does having the A allele mean I will get diabetes?
No. The rs780094 variant is associated with a statistical change in risk, but it does not determine whether you will develop diabetes. Many other factors, including lifestyle and other genetic markers, are far more influential.
Should I change my diet based on my rs780094 genotype?
You should not change your diet based solely on this genetic variant. Always consult with a registered dietitian or your doctor before making significant changes to your nutrition plan, especially if you have concerns about triglyceride or glucose levels.
Is rs780094 a diagnostic test for metabolic disease?
No, this variant is not used for clinical diagnosis. Metabolic conditions are diagnosed through clinical blood tests and physical examinations performed by a healthcare provider, not by genetic testing alone.
Where can I find more information about GCKR?
You can find reliable information about the GCKR gene and its functions through resources like MedlinePlus Genetics or the National Center for Biotechnology Information (NCBI) Gene database.
Sources & further reading
Educational information only, last refreshed 10/8/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs780094?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in GCKR
A significant SNP identified through fine-mapping that demonstrates a consistent effect on triglyceride levels across different ancestral populations.
A well-replicated regulatory/intronic variant within GCKR strongly associated with variation in fasting serum triglycerides, glucose levels, and lipid metabolism.
This variant in the GCKR gene is strongly linked to altered glucokinase regulation, influencing fasting blood triglyceride and glucose levels.
GCKR P446L modulates the glucokinase regulatory protein and balances triglyceride and glucose levels.
This variant in the glucokinase regulator (GCKR) locus is significantly associated with altered fasting plasma glucose, serum triglyceride levels, and hepatic fat accumulation.